Hepatitis C: HCV RNA Testing at No Greater Than Week 12 of Treatment

Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who are receiving antiviral treatment for whom quantitative HCV RNA testing was performed at no greater than 12 weeks from initiation of antiviral treatment

Date Reviewed: July 26, 2014

Measure Info

NQF 0398 CMS 87 NQF Endorsement Removed
Measure Type
Measure Steward
American Gastroenterological Association
Clinical Topic Area
Hepatitis C

Care Setting
Data Source
Electronic Health Data
Electronic Health Records

ACP does not support NQF 0398: “Hepatitis C: HCV RNA Testing at No Greater Than Week 12 of Treatment.” Although it is important to measure viral load to assess the efficacy of treatment, clinical guidelines for the treatment of Hepatitis C are evolving and the changes in treatment regimens may alter the appropriate interval and/or frequency of testing.